223
Participants
Start Date
July 24, 2020
Primary Completion Date
January 27, 2025
Study Completion Date
January 27, 2025
Pralsetinib
Administered orally
Carboplatin
Administered IV
Cisplatin
Administered IV
Pemetrexed
Administered IV
Pembrolizumab
Administered IV
Gemcitabine
Administered IV
Paclitaxel
Administered IV
Nab-Paclitaxel
Administered IV
Royal North Shore Hospital, St Leonards
UZ Antwerpen, Edegem
UniversitätsSpital Zürich, Zurich
Clinica CIMCA, San José
National Cancer Center, Goyang-si
Institut Paoli Calmettes, Marseille
Complejo Hospitalario Universitario A Coruña, A Coruña
Pius-Hospital, Oldenburg
Hospital General Universitario Gregorio Marañon, Madrid
Hospital Ramon y Cajal, Madrid
Hospital de Madrid Norte Sanchinarro- Centro Integral Oncologico Clara Campal, Madrid
Hospital Regional Universitario de Malaga, Málaga
CHU de Toulouse - Hôpital Larrey, Toulouse
Institut Bergonie CLCC Bordeaux, Bordeaux
Hopital de Pontchaillou, Rennes
IOV - Istituto Oncologico Veneto - IRCCS, Padua
?zmir Medical Point, Kar?iyaka
A.O.U. INTEGRATA DI VERONA-Ospedale Civile Maggiore Borgo Trento, Verona
Hospital Universitario Marques de Valdecilla, Santander
Ospedale Provinciale Santa Maria Delle Croci, Ravenna
Hosp Clinico Univ Lozano Blesa, Zaragoza
Azienda Ospedaliera Universitaria Pisana - Ospedale Cisanello, Pisa
CHRU Lille Service de Pneumologie et Oncologie Thoracique, Lille
Ospedale Clinicizzato SS Annunziata, Chieti
CHU Strasbourg - Nouvel Hopital Civil, Strasbourg
Klinik Schillerhöhe, Stuttgart
Hopital Bichat Claude Bernard, Paris
Hopital Tenon, Paris
Istituto Nazionale per lo Studio e la Cura dei Tumori Fondazione G. Pascale, Napoli
Asklepios-Fachkliniken Muenchen-Gauting, Gauting
Hôpital Ambroise Paré - Boulogne-Billancourt, Boulogne-Billancourt
Institut Gustave Roussy, Villejuif
Leopoldina-Krankenhaus Medizinische Klinik II, Schweinfurt
Hospital Britanico, Buenos Aires
Hospital Sao Lucas - PUCRS, Porto Alegre
Hospital A. C. Camargo, São Paulo
Universitätsklinikum Carl Gustav Carus, Medizinische Klinik I, Pneumologie MK1-A13, Dresden
St. James Hospital, Dublin
Istituto Nazionale Tumori Regina Elena, Rome
AZ. Ospedaliera San Giovanni - Addolorata, Rome
Kyushu University Hospital, Fukuoka
National Hospital Organization Himeji Medical Center, Hyōgo
Osaka International Cancer Institute, Osaka
Kansai Medical University Hospital, Osaka
Juntendo University Hospital, Tokyo
The Cancer Institute Hospital of JFCR, Tokyo
National Hospital Organization Yamaguchi - Ube Medical Center, Yamaguchi
Health Pharma Professional Research, Mexico City
NKI/AvL, Amsterdam
Maastricht University Medical Center, Maastricht
Hemato Oncología de Panamá Especializada, Panama City
Narod.Inst.Onkol. im. M.Sklodowskiej - Curie-Panst.Inst.Bad, Warsaw
IPO do Porto, Porto
Seoul National University Hospital, Seoul
Severance Hospital, Yonsei University Health System, Seoul
Asan Medical Center, Seoul
Insititut Catala D'Oncologia, L'Hospitalet de Llobregat
Hospital Universitari Vall d'Hebron, Barcelona
Karolinska Universitetssjukhuset, Solna, Stockholm
Adana City Hospital, Medical Oncology, Adana
Ankara Bilkent City Hospital, Ankara
Velindre Cancer Centre, Cardiff
Leicester Royal Infirmary, Leicester
University College Hospital, London
Guys & St Thomas Hospital, London
Royal Marsden Hospital, London
Christie Hospital Nhs Trust, Manchester
Royal Marsden Hospital, Sutton
Hoffmann-La Roche
INDUSTRY